About TPTF
TPTF is a venture capital firm founded in 2014. It is primarily based out of Taipei, Taiwan. As of Oct 2024, TPTF has invested in 16 companies. It primarily invests in Seed round in Indonesia based startups. Its investments are spread across a wide range of sectors from Life Sciences to High Tech and Enterprise Applications. Most recently it participated in the $***** Seed round of Rey Overall, TPTF portfolio has seen 5 IPOs and 4 acquisitions including key companies like Crown Bioscience, Quanergy Com and Applied BioCode. A lot of funds co-invest with TPTF, with names like MDI Ventures sharing a substantial percentage of its portfolio. TPTF has team of 11 people including 2 partners.Key Metrics
Team Members
Portfolio Count
Portfolio Sectors
Portfolio Locations
Rounds of Entry
Seed, Series C & 2 more
Portfolio IPOs
Portfolio Acquisitions
TPTF's List of Top Investments
TPTF has a portfolio of 16 companies. Their most notable investments are in Rey and Kata.Their portfolio spans across United States, Indonesia, Taiwan and 1 more locations. They have invested in Life Sciences, High Tech, Enterprise Applications and 12 other sectors, across stages such as Seed, Series C and 2 more. Here is the list of top investments by TPTF:Crown Bioscience develops drugs for cancer and CVMD (Cardiovascular and Metabolic Diseases). The company’s proprietary platform includes HuPrime that is a patient-derived xenograft (PDX) models which can be used for efficacy testing. It also offers oncology services, such as oncology databases, ex vivo services, human surrogate trials, in vitro and in vivo services, preclinical models (PDX, Humanized and Murine efficacy/PD) for CAR-T Therapy Evaluation (immuno-oncology) etc., CrownBio also has a variety of rodent and mouse models for the development of drugs for CVMD. The company also offers products, such as antibodies for in vivo and in-vitro studies, tissues for CVMD research, tumor samples for Oncology R&D, cytokines and growth factors for use in basic and preclinical research, recombinant proteins and cell lines for biological studies, immune checkpoint antibodies and tumor tissue microarrays. CrownBio has strategic partnerships with Xstrahl, a designer, and manufacturer of X-Ray solutions for radiation biology research and Horizon Discovery, a provider of advanced research tools and services for the development of personalized medicines. CrownBio acquired PreClinOmics, an in vivo preclinical company specializing in CVMD and renal disease research. The company has spun-off CBT pharmacueticals, an emerging life science oncology company.
Key facts about Crown Bioscience
- Founded Year: 2006
- Location: Santa Clara (United States)
- Last Known Valuation: $*****
- Stage: Acquired
- Total Funding till date: $85.9M
- Employee Count: 561 as on Aug 31, 2026
- Investors: The CID Group, Industrial Technology Investment Corporation and 16 Others
- Latest Funding Round: Grant (prize money), Sep 01, 2017, $*****
- Highlight: Acquired

2. Quanergy Com
Provider of AI-driven LiDAR sensing solutions. It offers hardware and software solutions for LiDAR sensing. It also provides various products including mechanical lidar sensors, solid-state lidar sensors, and perception software. Its features include real-time analysis for people counting, object detection, classification, and tracking. It has applications in mapping, smart cities, industrial automation, and social distancing.
Key facts about Quanergy Com
- Founded Year: 2012
- Location: Sunnyvale (United States)
- Stage: Public
- Total Funding till date: $160M
- Employee Count: 63 as on Aug 31, 2026
- Investors: Avitas Capital, Toba Capital and 30 Others
- Latest Funding Round: Series C, Apr 01, 2020, $*****
- Highlight: Public
Developer of assay testing kits and instruments for in vitro diagnostics, research, and other industrial applications. The company develops, manufactures, and commercializes multiplex diagnostic testing products that inlcudes testing assays that detect pathogens for gastrointestinal infections, respiratory infections, and other high-value diseases. Also, it offers a BioCode MDx-3000 system with a 17-plex Gastrointestinal Pathogen Panel (GPP) and a 17-plex Respiratory Pathogen Panel (RPP).
Key facts about Applied BioCode
- Founded Year: 2008
- Location: Santa Fe Springs (United States)
- Stage: Public
- Total Funding till date: $20.3M
- Employee Count: 75 as on Aug 31, 2026
- Investors: ID Ventures America, TPTF and 4 Others
- Latest Funding Round: Series A, Apr 07, 2016, $*****
- Highlight: Public
4. Kata
Provider of AI and SaaS-based conversational platform for business. It offers a dialogue engine that allows brands to operate a chatbot on various platforms such as LINE, Facebook, Twitter, BBM, and Telegram. It includes product marketing, sales transaction, and market research.
Key facts about Kata
- Founded Year: 2015
- Location: Indonesia
- Stage: Series B
- Total Funding till date: $3.5M
- Employee Count: 91 as on Aug 31, 2026
- Investors: Convergence Ventures, Red Sails Investments and 8 Others
- Latest Funding Round: Series B, Nov 25, 2020, $*****
- Highlight: Editors' Pick
5. Zymergen
Platform utilizing genomics and machine learning to research and develop novel materials. It is a biotechnology company that specializes in designing and producing molecules, microbes, and materials for diverse end markets through the use of genomics and machine learning. The company partners with nature to create innovative solutions across various industries. Their products cater to diverse applications, including crop protection, food preservation, and animal nutrition.
Key facts about Zymergen
- Founded Year: 2013
- Location: Emeryville (United States)
- Stage: Acquired
- Total Funding till date: $883M
- Employee Count: 51 as on Sep 29, 2025
- Investors: Perceptive Advisors, Baillie Gifford and 38 Others
- Latest Funding Round: Series D, Sep 08, 2020, $*****
- Highlight: Acquired
TPTF's Year-on-Year Investment Trends
TPTF has invested in 16 companies over the last 10 years, with an average of 1 new investment annually in the last 10 years. Its most recent first time investment was in Rey and most recent follow-on round was in Rey.Year | No. of Investments | ||
|---|---|---|---|
1st Round | Follow-on | Total | |
2026 (YTD) | 0 | 0 | 0 |
2025 | 0 | 0 | 0 |
2024 | 0 | 1 | 1 |
2023 | 0 | 0 | 0 |
2022 | 0 | 1 | 1 |
2021 | 2 | 0 | 2 |
2020 | 0 | 2 | 2 |
2019 | 1 | 0 | 1 |
2018 | 1 | 0 | 1 |
2017 | 1 | 0 | 1 |
TPTF's Investments by Stage
TPTF has made 2 investments in Seed stage with an average round size of $2M, 2 investments in Series C stage with an average round size of $230M, 1 investment in Series A stage with an average round size of $3.5M and 1 investment in Series B stage with an average round size of $23.5M.Stage of entry | No. of Investments |
|---|---|
Seed | 2 |
Series C | 2 |
Series A | 1 |
Series B | 1 |
Note: We have considered here, only first round of investments
TPTF's Investments by Sector
TPTF has a diverse portfolio, with companies operating in the Enterprise Applications, HealthTech, High Tech, Sustainability Tech and Business Services. Notably, it has invested in 14 Enterprise (B2B) companies, 12 Tech companies, 7 Software companies and at least 3 companies focusing on Saas.Sector | No. of Investments |
|---|---|
Enterprise Applications | 3 |
HealthTech | 2 |
High Tech | 2 |
Sustainability Tech | 2 |
Business Services | 1 |
Others | 4 |
Note: We have considered here, only first round of investments
TPTF's Investments by Geography
TPTF has made most investments in Indonesia (3), followed by United States where it has made 2 investments.Country | No. of Investments |
|---|---|
Indonesia | 3 |
United States | 2 |
China | 1 |
Note: We have considered here, only first round of investments
TPTF's recent investments
TPTF has not made any investment in 2026 so far.Here are the most recent investments by TPTF:
Date | Company | Location | Round Details | Round Amount | Co-Investors |
|---|---|---|---|---|---|
Oct 01, 2024 | Indonesia | Seed | 7619 | [+4] | |
Jul 06, 2022 | Indonesia | Seed | 8310 | [+1] | |
Sep 13, 2021 | Indonesia | Seed | 5364 | - | |
Jun 04, 2021 | Indonesia | Seed | 3541 | [+1] | |
Nov 25, 2020 | Indonesia | Series B | 4233 |
IPOs and Publicly Listed companies in TPTF's Portfolio
5 of TPTF's portfolio companies have become public. Googol Technology got listed on the Shenzhen Stock Exchange (SZSE), in Aug 2023 at marketcap of $659M and MegaPro Biomedical got listed on the Taipei Stock Exchange (TT).Here are TPTF's portfolio companies that went public:
Company | IPO Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Aug 15, 2023 | - | - | 4120 | |
Oct 19, 2021 | - | - | 3399 | |
Mar 19, 2021 | Jul 19, 2019 | Series C | 9258 | |
Jun 09, 2020 | - | - | 1990 | |
Apr 24, 2020 | - | - | 1303 |
Acquired companies in TPTF's Portfolio
4 companies from TPTF's portfolio have been acquired. The most recent acquisition was Crown Bioscience in Nov 2025 by Aidikang Medical Laboratory Center for $*****.Here are TPTF's portfolio companies that got acquired most recently:
Company | Acquisition Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Nov 13, 2025 | - | - | 4293 | |
Aug 23, 2023 | - | - | 8187 | |
Jul 25, 2022 | Dec 17, 2018 | Series C | 4800 | |
Jul 08, 2020 | - | - | 8326 |
Team profile of TPTF
TPTF has a team of 11 members including 2 Partners, 2 Venture Partners and 1 Principal located in Taiwan, China and 1 more location. TPTF's team does not sit on the board of any company as of now.Here is a list of top team members in TPTF:
Name | Designation | Location | Board Memberships | Contact Details |
|---|---|---|---|---|
Partner | United States | - | - | |
Partner | Taiwan | - | ||
Venture Partner | Hong Kong | - | ||
Venture Partner | - | - | ||
Principal | Taipei | - |
Co-investors of TPTF
Over the past 10 years, 53 investors have co-invested in TPTF's portfolio companies. This includes funds and angels.
- Invested before TPTF: Convergence Ventures, Spiral Ventures and 19 others have invested in rounds before TPTF. There is 1 company where Convergence Ventures has invested before TPTF and 1 company where Spiral Ventures has invested before TPTF.
- Top Co-investors of TPTF: 16 investors entered a company along with TPTF. These include investors like MDI Ventures (2 companies).
- Invested after TPTF: A total of 16 investors have invested in TPTF's portfolio after their investments. Top Investors include Baillie Gifford (1 company), Baron Funds (1 company) and Perceptive Advisors (1 company).
Recent News related to TPTF
•
Insurtech Rey Raises US$3.5 Million in FundingICONOMICS•Oct 01, 2024•Rey, CyberAgent Capital, Gametraco, TPTF and 2 others
•
Insurtech Startup Rey Announces Additional Funding of IDR 53 BillionDailysocial•Sep 30, 2024•Rey, CyberAgent Capital, Gametraco, TPTF and 2 others
•
•
•
Prixa Raises $3M in FundingFinSMEs•Jun 07, 2021•Prixa, MDI Ventures, TPTF, Siloam Hospitals and 6 others
•
•
Finch Therapeutics Raises $90M in Series D FinancingFinSMEs•Sep 17, 2020•Finch Therapeutics, Willett Advisors, TPTF, SIG SAUER and 12 others
•
Clinical Stage Therapeutics Group Raises $53MLaw360•Aug 22, 2019•Finch Therapeutics, OCV Partners, SIG, Symbiosis and 5 others
•
BRIEF-Heal - Closed $20 Million In Additional FundingReuters•May 22, 2018•CenterWell Senior Primary Care, RLJ Equity Partners, TPTF, Fidelity Investments and 8 others
